M&A Deal Summary

Upstryve Acquires Atlas Publishing

On June 27, 2017, Upstryve acquired e-commerce company Atlas Publishing

Acquisition Highlights
  • This is Upstryve’s 1st transaction in the E-Commerce sector.
  • This is Upstryve’s 2nd transaction in the United States.
  • This is Upstryve’s 1st transaction in Texas.

M&A Deal Summary
Date 2017-06-27
Target Atlas Publishing
Sector E-Commerce
Buyer(s) Upstryve
Deal Type Add-on Acquisition

Target

Atlas Publishing

Houston, Texas, United States
W. Marketing, Inc. is a provider of widest selection of electrical and construction trade reference materials to engineers, electrical training instructors, builders, building maintenance and professionals in the construction and electrical industries. W. Marketing, Inc. was established in 2006 and is based in Houston, Texas.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Upstryve

Houston, Texas, United States
Category Company
Founded 2020
Sector Education
Revenue 9M USD (2017)
DESCRIPTION

Upstryve is an international education, training, and career advancement company with a focus on vocational and skilled trades headquartered in southern Florida. Upstryve operates through its four brands including Upstryve, One Exam Prep, North American Crane Bureau Group and Disco Learning Media. Upstryve was formed in 2020 and is based in Houston, Texas.

DEAL STATS #
Overall 3 of 5
Sector (E-Commerce) 1 of 1
Type (Add-on Acquisition) 2 of 4
State (Texas) 1 of 2
Country (United States) 2 of 4
Year (2017) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-01 Alchemia Oncology Pty

Clayton, Australia

Alchemia Oncology Pty Limited has a robust collection of clinical and pre-clinical oncology assets, which include the HyACT Drug Delivery Platform, a portfolio of targeted therapeutics which are designed to exploit the unique structure and inherent biological properties of Hyaluronic Acid. Drug candidates in the portfolio range from pre-clinical through phase 3. Panther intends to file a new phase 3 protocol against an open IND with the FDA for HA-Irinotecan in 2015, in addition to advancing the other phase 2 and phase 1b clinical drug candidates.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-07 Cranbury International

Montpelier, Vermont, United States

Cranbury International LLC is an exporter of educational and reference materials to governmental institutions and private sector markets. Cranbury International LLC is based in Montpelier, Vermont.

Buy -
Mergr

Product

Company

Legal